Cargando…
Correction to: Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496613/ https://www.ncbi.nlm.nih.gov/pubmed/34037812 http://dx.doi.org/10.1007/s00125-021-05460-0 |
| _version_ | 1784579788986384384 |
|---|---|
| author | Ji, Linong Du, Ying Xu, Min Zhou, Xiangjun Mo, Zhaohui Ma, Jianhua Li, Jiarui Li, Yufeng Lin, Jingna Wang, Yanjun Yang, Jing Song, Weihong Jin, Hui Pang, Shuguang Liu, Hui Li, Ping Liu, Jie Yao, Minxiu Li, Wenhui Jiang, Xiaohong Shen, Feixia Geng, Houfa Zhou, Haifeng Ran, Jianmin Lei, Minxiang Du, Yinghong Ye, Shandong Guan, Qingbo Lv, Wenshan Tan, Huiwen Chen, Tao Yang, Jinkui Qin, Guijun Li, Shiyun Chen, Lei |
| author_facet | Ji, Linong Du, Ying Xu, Min Zhou, Xiangjun Mo, Zhaohui Ma, Jianhua Li, Jiarui Li, Yufeng Lin, Jingna Wang, Yanjun Yang, Jing Song, Weihong Jin, Hui Pang, Shuguang Liu, Hui Li, Ping Liu, Jie Yao, Minxiu Li, Wenhui Jiang, Xiaohong Shen, Feixia Geng, Houfa Zhou, Haifeng Ran, Jianmin Lei, Minxiang Du, Yinghong Ye, Shandong Guan, Qingbo Lv, Wenshan Tan, Huiwen Chen, Tao Yang, Jinkui Qin, Guijun Li, Shiyun Chen, Lei |
| author_sort | Ji, Linong |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8496613 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84966132021-10-29 Correction to: Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study Ji, Linong Du, Ying Xu, Min Zhou, Xiangjun Mo, Zhaohui Ma, Jianhua Li, Jiarui Li, Yufeng Lin, Jingna Wang, Yanjun Yang, Jing Song, Weihong Jin, Hui Pang, Shuguang Liu, Hui Li, Ping Liu, Jie Yao, Minxiu Li, Wenhui Jiang, Xiaohong Shen, Feixia Geng, Houfa Zhou, Haifeng Ran, Jianmin Lei, Minxiang Du, Yinghong Ye, Shandong Guan, Qingbo Lv, Wenshan Tan, Huiwen Chen, Tao Yang, Jinkui Qin, Guijun Li, Shiyun Chen, Lei Diabetologia Correction Springer Berlin Heidelberg 2021-05-26 2021 /pmc/articles/PMC8496613/ /pubmed/34037812 http://dx.doi.org/10.1007/s00125-021-05460-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
| spellingShingle | Correction Ji, Linong Du, Ying Xu, Min Zhou, Xiangjun Mo, Zhaohui Ma, Jianhua Li, Jiarui Li, Yufeng Lin, Jingna Wang, Yanjun Yang, Jing Song, Weihong Jin, Hui Pang, Shuguang Liu, Hui Li, Ping Liu, Jie Yao, Minxiu Li, Wenhui Jiang, Xiaohong Shen, Feixia Geng, Houfa Zhou, Haifeng Ran, Jianmin Lei, Minxiang Du, Yinghong Ye, Shandong Guan, Qingbo Lv, Wenshan Tan, Huiwen Chen, Tao Yang, Jinkui Qin, Guijun Li, Shiyun Chen, Lei Correction to: Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study |
| title | Correction to: Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study |
| title_full | Correction to: Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study |
| title_fullStr | Correction to: Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study |
| title_full_unstemmed | Correction to: Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study |
| title_short | Correction to: Efficacy and safety of PEGylated exenatide injection (PB-119) in treatment-naive type 2 diabetes mellitus patients: a Phase II randomised, double-blind, parallel, placebo-controlled study |
| title_sort | correction to: efficacy and safety of pegylated exenatide injection (pb-119) in treatment-naive type 2 diabetes mellitus patients: a phase ii randomised, double-blind, parallel, placebo-controlled study |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8496613/ https://www.ncbi.nlm.nih.gov/pubmed/34037812 http://dx.doi.org/10.1007/s00125-021-05460-0 |
| work_keys_str_mv | AT jilinong correctiontoefficacyandsafetyofpegylatedexenatideinjectionpb119intreatmentnaivetype2diabetesmellituspatientsaphaseiirandomiseddoubleblindparallelplacebocontrolledstudy AT duying correctiontoefficacyandsafetyofpegylatedexenatideinjectionpb119intreatmentnaivetype2diabetesmellituspatientsaphaseiirandomiseddoubleblindparallelplacebocontrolledstudy AT xumin correctiontoefficacyandsafetyofpegylatedexenatideinjectionpb119intreatmentnaivetype2diabetesmellituspatientsaphaseiirandomiseddoubleblindparallelplacebocontrolledstudy AT zhouxiangjun correctiontoefficacyandsafetyofpegylatedexenatideinjectionpb119intreatmentnaivetype2diabetesmellituspatientsaphaseiirandomiseddoubleblindparallelplacebocontrolledstudy AT mozhaohui correctiontoefficacyandsafetyofpegylatedexenatideinjectionpb119intreatmentnaivetype2diabetesmellituspatientsaphaseiirandomiseddoubleblindparallelplacebocontrolledstudy AT majianhua correctiontoefficacyandsafetyofpegylatedexenatideinjectionpb119intreatmentnaivetype2diabetesmellituspatientsaphaseiirandomiseddoubleblindparallelplacebocontrolledstudy AT lijiarui correctiontoefficacyandsafetyofpegylatedexenatideinjectionpb119intreatmentnaivetype2diabetesmellituspatientsaphaseiirandomiseddoubleblindparallelplacebocontrolledstudy AT liyufeng correctiontoefficacyandsafetyofpegylatedexenatideinjectionpb119intreatmentnaivetype2diabetesmellituspatientsaphaseiirandomiseddoubleblindparallelplacebocontrolledstudy AT linjingna correctiontoefficacyandsafetyofpegylatedexenatideinjectionpb119intreatmentnaivetype2diabetesmellituspatientsaphaseiirandomiseddoubleblindparallelplacebocontrolledstudy AT wangyanjun correctiontoefficacyandsafetyofpegylatedexenatideinjectionpb119intreatmentnaivetype2diabetesmellituspatientsaphaseiirandomiseddoubleblindparallelplacebocontrolledstudy AT yangjing correctiontoefficacyandsafetyofpegylatedexenatideinjectionpb119intreatmentnaivetype2diabetesmellituspatientsaphaseiirandomiseddoubleblindparallelplacebocontrolledstudy AT songweihong correctiontoefficacyandsafetyofpegylatedexenatideinjectionpb119intreatmentnaivetype2diabetesmellituspatientsaphaseiirandomiseddoubleblindparallelplacebocontrolledstudy AT jinhui correctiontoefficacyandsafetyofpegylatedexenatideinjectionpb119intreatmentnaivetype2diabetesmellituspatientsaphaseiirandomiseddoubleblindparallelplacebocontrolledstudy AT pangshuguang correctiontoefficacyandsafetyofpegylatedexenatideinjectionpb119intreatmentnaivetype2diabetesmellituspatientsaphaseiirandomiseddoubleblindparallelplacebocontrolledstudy AT liuhui correctiontoefficacyandsafetyofpegylatedexenatideinjectionpb119intreatmentnaivetype2diabetesmellituspatientsaphaseiirandomiseddoubleblindparallelplacebocontrolledstudy AT liping correctiontoefficacyandsafetyofpegylatedexenatideinjectionpb119intreatmentnaivetype2diabetesmellituspatientsaphaseiirandomiseddoubleblindparallelplacebocontrolledstudy AT liujie correctiontoefficacyandsafetyofpegylatedexenatideinjectionpb119intreatmentnaivetype2diabetesmellituspatientsaphaseiirandomiseddoubleblindparallelplacebocontrolledstudy AT yaominxiu correctiontoefficacyandsafetyofpegylatedexenatideinjectionpb119intreatmentnaivetype2diabetesmellituspatientsaphaseiirandomiseddoubleblindparallelplacebocontrolledstudy AT liwenhui correctiontoefficacyandsafetyofpegylatedexenatideinjectionpb119intreatmentnaivetype2diabetesmellituspatientsaphaseiirandomiseddoubleblindparallelplacebocontrolledstudy AT jiangxiaohong correctiontoefficacyandsafetyofpegylatedexenatideinjectionpb119intreatmentnaivetype2diabetesmellituspatientsaphaseiirandomiseddoubleblindparallelplacebocontrolledstudy AT shenfeixia correctiontoefficacyandsafetyofpegylatedexenatideinjectionpb119intreatmentnaivetype2diabetesmellituspatientsaphaseiirandomiseddoubleblindparallelplacebocontrolledstudy AT genghoufa correctiontoefficacyandsafetyofpegylatedexenatideinjectionpb119intreatmentnaivetype2diabetesmellituspatientsaphaseiirandomiseddoubleblindparallelplacebocontrolledstudy AT zhouhaifeng correctiontoefficacyandsafetyofpegylatedexenatideinjectionpb119intreatmentnaivetype2diabetesmellituspatientsaphaseiirandomiseddoubleblindparallelplacebocontrolledstudy AT ranjianmin correctiontoefficacyandsafetyofpegylatedexenatideinjectionpb119intreatmentnaivetype2diabetesmellituspatientsaphaseiirandomiseddoubleblindparallelplacebocontrolledstudy AT leiminxiang correctiontoefficacyandsafetyofpegylatedexenatideinjectionpb119intreatmentnaivetype2diabetesmellituspatientsaphaseiirandomiseddoubleblindparallelplacebocontrolledstudy AT duyinghong correctiontoefficacyandsafetyofpegylatedexenatideinjectionpb119intreatmentnaivetype2diabetesmellituspatientsaphaseiirandomiseddoubleblindparallelplacebocontrolledstudy AT yeshandong correctiontoefficacyandsafetyofpegylatedexenatideinjectionpb119intreatmentnaivetype2diabetesmellituspatientsaphaseiirandomiseddoubleblindparallelplacebocontrolledstudy AT guanqingbo correctiontoefficacyandsafetyofpegylatedexenatideinjectionpb119intreatmentnaivetype2diabetesmellituspatientsaphaseiirandomiseddoubleblindparallelplacebocontrolledstudy AT lvwenshan correctiontoefficacyandsafetyofpegylatedexenatideinjectionpb119intreatmentnaivetype2diabetesmellituspatientsaphaseiirandomiseddoubleblindparallelplacebocontrolledstudy AT tanhuiwen correctiontoefficacyandsafetyofpegylatedexenatideinjectionpb119intreatmentnaivetype2diabetesmellituspatientsaphaseiirandomiseddoubleblindparallelplacebocontrolledstudy AT chentao correctiontoefficacyandsafetyofpegylatedexenatideinjectionpb119intreatmentnaivetype2diabetesmellituspatientsaphaseiirandomiseddoubleblindparallelplacebocontrolledstudy AT yangjinkui correctiontoefficacyandsafetyofpegylatedexenatideinjectionpb119intreatmentnaivetype2diabetesmellituspatientsaphaseiirandomiseddoubleblindparallelplacebocontrolledstudy AT qinguijun correctiontoefficacyandsafetyofpegylatedexenatideinjectionpb119intreatmentnaivetype2diabetesmellituspatientsaphaseiirandomiseddoubleblindparallelplacebocontrolledstudy AT lishiyun correctiontoefficacyandsafetyofpegylatedexenatideinjectionpb119intreatmentnaivetype2diabetesmellituspatientsaphaseiirandomiseddoubleblindparallelplacebocontrolledstudy AT chenlei correctiontoefficacyandsafetyofpegylatedexenatideinjectionpb119intreatmentnaivetype2diabetesmellituspatientsaphaseiirandomiseddoubleblindparallelplacebocontrolledstudy |